Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Las Vegas, NV
SEC filing record 1 source field available
Fiscal year end
31 December
Raphael Pharmaceutical Inc. has filed 176 SEC EDGAR filings since 24 Oct 2007

SEC filing history

Showing 51-75 of 105 matching filings.

Per page
25
Current page
3
8-K/A File 000-53002

AMENDMENT NO. 1 TO FORM 8-K

Filing date
26 Jan 2023
Reporting date
07 Jul 2022
Next action
Verify source filing
10-Q File 000-53002

QUARTERLY REPORT

Filing date
14 Nov 2022
Reporting date
30 Sep 2022
Next action
Verify source filing
8-K File 000-53002

CURRENT REPORT

Filing date
24 Oct 2022
Reporting date
07 Oct 2022
Next action
Verify source filing
10-Q File 000-53002

QUARTERLY REPORT

Filing date
12 Aug 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
EFFECT File 333-265878

EFFECT filing

Filing date
08 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53002

CURRENT REPORT

Filing date
07 Jul 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
06 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
30 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-265878

REGISTRATION STATEMENT

Filing date
28 Jun 2022
Reporting date
Not listed
Next action
Verify source filing
EFFECT File 333-260766

EFFECT filing

Filing date
27 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-260766

POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1

Filing date
26 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-53002

QUARTERLY REPORT

Filing date
16 May 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
10-K File 000-53002

ANNUAL REPORT

Filing date
30 Mar 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
3

3 filing

Filing date
19 Jan 2022
Reporting date
27 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
19 Jan 2022
Reporting date
27 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
19 Jan 2022
Reporting date
27 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
19 Jan 2022
Reporting date
27 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-260766

EFFECT filing

Filing date
01 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
29 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
24 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-260766

AMENDMENT NO. 1 TO FORM S-1

Filing date
24 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
19 Nov 2021
Reporting date
27 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
18 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-53002

QUARTERLY REPORT

Filing date
16 Nov 2021
Reporting date
30 Sep 2021
Next action
Verify source filing
NT 10-Q File 000-53002

NOTIFICATION OF LATE FILING

Filing date
15 Nov 2021
Reporting date
30 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .